Dr. Chiara Veronese is a Clinical Pharmacologist and specialized researcher at the Fondazione IRCCS Istituto Nazionale dei Tumori (INT) in Milan, where she has been a key member of the Respiratory Diseases Unit for over ten years. Her career is defined by a deep commitment to tobacco control, clinical pharmacology, and the primary prevention of cancer through lifestyle and environmental interventions.
A specialist in Clinical Pharmacology and Toxicology, Dr. Veronese’s research focuses on the efficacy and safety of smoking cessation treatments. She has led several high-impact projects at INT, serving as Principal Investigator for national training initiatives designed to integrate smoking cessation protocols into oncology departments.
She has authored or co-authored numerous scientific articles in peer-reviewed national and international journals, underscoring her substantial contributions to tobacco control and public health research.
Dr. Veronese is a member of the executive board of the Italian Society of Tobaccology (SITAB), a non-profit scientific society dedicated to tobacco prevention, cessation, and related diseases.